Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Hematologic Malignancies
•
Dermatology
•
Drug Eruptions
Is rechallenge with nivolumab appropriate after a non–SJS EM-like vesicobullous eruption with limited mucosal disease?
Related Questions
Would you give adjuvant radiation after complete resection of a small primary cutaneous follicular lymphoma of the scalp?
What is your standard diagnostic workup to confirm GVHD in a patient post-BMT with skin rash and jaundice?
Does the presence of paraneoplastic pemphigus influence your treatment options in CLL?
What are your preferred alternative biologic agents for Blau Syndrome when anti-TNFα therapies are contraindicated?
Is there a general consensus on margins to use when treating SCCIS or BCC with ED&C?
Have you had success in treating extensive lichen nitidus with a systemic therapy?
What is the role of hair transplantation for scarring alopecias like lichen planopilaris?
Why/How do patients report seeing flashes of light when receiving Pulsed Dye Light (PDL) treatments on the face?
Do you feel there is any role for neoadjuvant imatinib in pediatric DFSP with the classic translocation given that surgery can introduce high morbidity?
What specific historical questions do you prioritize when evaluating hair loss to identify features suggestive of autoimmune or connective tissue disorders?
